These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34527683)

  • 41. INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.
    Arora A; Singh SP; Kumar A; Saraswat VA; Aggarwal R; Bangar M; Bhaumik P; Devarbhavi H; Dhiman RK; Dixit VK; Goel A; Goswami B; Kapoor D; Madan K; Narayan J; Nijhawan S; Pandey G; Rai RR; Sahu MK; Saraf N; Shalimar ; Shenoy T; Thomas V; Wadhawan M;
    J Clin Exp Hepatol; 2018 Mar; 8(1):58-80. PubMed ID: 29743798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study.
    Zhang J; Du X; Zhou Z; Lv F; Yu Y
    J Int Med Res; 2019 Jan; 47(1):122-132. PubMed ID: 30213226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An Assessment of Upper Limits of Normal for ALT and the Impact on Evaluating Natural Course of Chronic Hepatitis B Virus Infection in Chinese Children.
    Pan XB; Lu YQ; Lin SZ; Ye J; Wu N; Lou YY; Ni L; Han JC; Zheng XQ; Wei L
    Am J Gastroenterol; 2018 Nov; 113(11):1660-1668. PubMed ID: 30353056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
    Kim EJ; Yeon JE; Kwon OS; Lee HN; Shin SK; Kang SH; Byun KS; Kim JH; Kwon SY; Suh SJ; Yim HJ; Kim YS; Kim JH
    Dig Dis Sci; 2017 Mar; 62(3):808-816. PubMed ID: 28035553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Impact of cessation of antiviral therapy at delivery on postpartum liver function in mothers with chronic hepatitis B virus infection].
    Guo HJ; Gao YF; Liu HY; He HT; Huang MT; Cai DC; Liao DD; Li JN; Yin XR; Liu ZH; Hu J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):112-117. PubMed ID: 30818915
    [No Abstract]   [Full Text] [Related]  

  • 46. Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1762-9. PubMed ID: 23808759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic diversity, viraemic and aminotransferases levels in chronic infected hepatitis B patients from Cameroon.
    Tufon KA; Meriki HD; Anong DN; Mbunkah HA; Nkuo-Akenji T
    BMC Res Notes; 2016 Feb; 9():117. PubMed ID: 26899506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural history of chronic hepatitis B and C.
    Imperial JC
    J Gastroenterol Hepatol; 1999 May; 14 Suppl():S1-5. PubMed ID: 10382630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of FibroScan test in antiviral therapy for HBV-infected patients with ALT <2 upper limit of normal.
    Han XZ; Zhang SF; Yi JY; Wang B; Sun HQ
    Open Life Sci; 2020; 15(1):418-422. PubMed ID: 33817230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend.
    Wong GL
    Clin Mol Hepatol; 2018 Jun; 24(2):108-113. PubMed ID: 29353469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
    Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
    Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M; Sarin SK; Hissar S; Pande C; Sakhuja P; Sharma BC; Chauhan R; Bose S
    Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Correlation between alanine aminotransaminase level and hepatocellular carcinoma in antiviral therapy of chronic viral hepatitis].
    Zhang L; Hu P
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):838-841. PubMed ID: 31941238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treating Immune-tolerant Hepatitis B.
    Tseng TC; Kao JH
    J Viral Hepat; 2015 Feb; 22(2):77-84. PubMed ID: 25424771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B virus genotypes, precore mutations, and basal core promoter mutations in HBV-infected Chinese patients with persistently normal alanine aminotransferase and low serum HBV-DNA levels.
    Shi M; Zhang Y; Zhang J; Liu W; Xing L
    Braz J Infect Dis; 2012; 16(1):52-6. PubMed ID: 22358356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of liver histological changes and a sustained virological response to peginterferon among chronic hepatitis B e antigen-positive patients with normal or minimally elevated alanine aminotransferase levels.
    Chen J; Xu CR; Xi M; Hu WW; Tang ZH; Zang GQ
    J Viral Hepat; 2017 Jul; 24(7):573-579. PubMed ID: 28107601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.
    Göbel T; Erhardt A; Herwig M; Poremba C; Baldus SE; Sagir A; Heinzel-Pleines U; Häussinger D
    J Med Virol; 2011 Jun; 83(6):968-73. PubMed ID: 21503908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indications for therapy in hepatitis B.
    Degertekin B; Lok AS
    Hepatology; 2009 May; 49(5 Suppl):S129-37. PubMed ID: 19399799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
    Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.